Back to Epoch Investment Partners, Inc. Epoch Investment Partners, Inc.

ABBVABBV

Showing 8 of 30 quarters

Position history for Epoch Investment Partners, Inc.Epoch Investment Partners, Inc.'s holdings in AbbVie Inc.

Yes. Epoch Investment Partners holds 1,376,588 shares of ABBV (AbbVie), worth $346.4M, as of its Q2 2026 13F filing. It reduced the position by 129,554 shares (-8.6%) from Q1 2026. Epoch Investment Partners has held ABBV in every 13F on record since Q1 2019, 30 quarterly filings. ABBV is 2.0% of Epoch Investment Partners' reported 13F portfolio.

Current Value

$346.4M

Current Shares

1.4M

Total Value Change

+$165.2M

Total Shares Change

+458,818

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-8.6%
$346.4M2.0%$248.34
0
2026-Q1
Increased
1.5M
+11.2%
$327.6M2.0%$212.87
54
2025-Q4
Decreased
1.4M
-9.5%
$309.4M1.8%$221.85
0
2025-Q3
Increased
1.5M
+10.2%
$346.6M1.9%$223.20
54
2025-Q2
Increased
1.4M
+67.9%
$252.2M1.3%$177.40
72
2025-Q1
Decreased
809,041
-1.1%
$169.5M0.9%$198.41
0
2024-Q4
Decreased
818,408
-10.8%
$145.4M0.7%$166.71
0
2024-Q3
Decreased
917,770
-1.3%
$181.2M0.8%$183.80
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used